Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Faissner

Showing results (61-70 of 82) with videos related to

Pageof 9
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 1, 2017
Unexpected additive effects of minocycline and hydroxychloroquine in models of multiple sclerosis: Prospective combination treatment for progressive disease?Simon Faissner, Yasamin Mahjoub, Manoj Mishra, et al.
Journal of Neuroinflammation|June 16, 2018
Laquinimod protects the optic nerve and retina in an experimental autoimmune encephalomyelitis modelAnna T Wilmes, Sabrina Reinehr, Sandra Kühn, et al.
Frontiers in Immunology|May 1, 2025
The P2X7R-antagonist AFC-5128 ameliorates chronic experimental autoimmune encephalomyelitis in a preventive and therapeutic paradigmRobert Hoffrogge, Anna Karachunskaya, Neele Heitmann, et al.
Journal of Neurology|July 22, 2024
Quality of life and tolerability of B-cell directed therapy of multiple sclerosis with ofatumumab in a patient-centered real-world observational studyAnna-Sophia Karl, Rafael Klimas, Melina Katsimpoura, et al.
Therapeutic Advances in Neurological Disorders|December 15, 2022
Preserved T-cell response in anti-CD20-treated multiple sclerosis patients following SARS-CoV-2 vaccinationSimon Faissner, Neele Heitmann, Ricarda Rohling, et al.
Experimental Neurology|August 24, 2014
Cytoplasmic HIV-RNA in monocytes determines microglial activation and neuronal cell death in HIV-associated neurodegenerationSimon Faissner, Björn Ambrosius, Kirsten Schanzmann, et al.
Chemical Science|October 10, 2017
Multi-target-directed phenol-triazole ligands as therapeutic agents for Alzheimer's diseaseMichael R Jones, Emilie Mathieu, Christine Dyrager, et al.
Frontiers in Immunology|August 8, 2025
Correction: The P2X7R-antagonist AFC-5128 ameliorates chronic experimental autoimmune encephalomyelitis in a preventive and therapeutic paradigmRobert Hoffrogge, Anna Karachunskaya, Neele Heitmann, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 7, 2014
Interferon-beta affects mitochondrial activity in CD4+ lymphocytes: Implications for mechanism of action in multiple sclerosisAiden Haghikia, Simon Faissner, Derek Pappas, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 5, 2019
Smad7 in intestinal CD4<sup>+</sup> T cells determines autoimmunity in a spontaneous model of multiple sclerosisSteffen Haupeltshofer, Teresa Leichsenring, Sarah Berg, et al.
Pageof 9

Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 1, 2017
Unexpected additive effects of minocycline and hydroxychloroquine in models of multiple sclerosis: Prospective combination treatment for progressive disease?Simon Faissner, Yasamin Mahjoub, Manoj Mishra, et al.
Journal of Neuroinflammation|June 16, 2018
Laquinimod protects the optic nerve and retina in an experimental autoimmune encephalomyelitis modelAnna T Wilmes, Sabrina Reinehr, Sandra Kühn, et al.
Frontiers in Immunology|May 1, 2025
The P2X7R-antagonist AFC-5128 ameliorates chronic experimental autoimmune encephalomyelitis in a preventive and therapeutic paradigmRobert Hoffrogge, Anna Karachunskaya, Neele Heitmann, et al.
Journal of Neurology|July 22, 2024
Quality of life and tolerability of B-cell directed therapy of multiple sclerosis with ofatumumab in a patient-centered real-world observational studyAnna-Sophia Karl, Rafael Klimas, Melina Katsimpoura, et al.
Therapeutic Advances in Neurological Disorders|December 15, 2022
Preserved T-cell response in anti-CD20-treated multiple sclerosis patients following SARS-CoV-2 vaccinationSimon Faissner, Neele Heitmann, Ricarda Rohling, et al.
Experimental Neurology|August 24, 2014
Cytoplasmic HIV-RNA in monocytes determines microglial activation and neuronal cell death in HIV-associated neurodegenerationSimon Faissner, Björn Ambrosius, Kirsten Schanzmann, et al.
Chemical Science|October 10, 2017
Multi-target-directed phenol-triazole ligands as therapeutic agents for Alzheimer's diseaseMichael R Jones, Emilie Mathieu, Christine Dyrager, et al.
Frontiers in Immunology|August 8, 2025
Correction: The P2X7R-antagonist AFC-5128 ameliorates chronic experimental autoimmune encephalomyelitis in a preventive and therapeutic paradigmRobert Hoffrogge, Anna Karachunskaya, Neele Heitmann, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 7, 2014
Interferon-beta affects mitochondrial activity in CD4+ lymphocytes: Implications for mechanism of action in multiple sclerosisAiden Haghikia, Simon Faissner, Derek Pappas, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 5, 2019
Smad7 in intestinal CD4<sup>+</sup> T cells determines autoimmunity in a spontaneous model of multiple sclerosisSteffen Haupeltshofer, Teresa Leichsenring, Sarah Berg, et al.
Pageof 9